8037.HK · CH BIOTECH SER
Hong Kong · RS rating 21 · As of 2026-10-14
| Price | 0.56 HKD |
|---|---|
| 1-day change | -0.9% |
| RS rating (overall / 1M / 3M / 12M) | 21 / 23 / 20 / 27 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 21 / 8 |
| Industry group (rank) | Other Healthcare (20) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +45.1% |
| Market cap (USD) | $62.5M |